Animal-free Dose Response Studies with the 3D CoSeedis™ Dose Response Assay

abc biopply’s services provide reliable and more predictive preclinical disease models for compound testing. Not only do we help customers to setup, grow and analyze complex, yet easily assessable 3D cell cultures, we also develop unique and highly sensitive novel assays based on the 3D CoSeedis™ technology.
The 3D CoSeedis™ Dose Response Assay has been developed and validated extensively to increase predictiveness and sensitivity of ex vivo disease models while at the same time reduce the number of test animals required. Consequently, it provides reliable dose response data at much lower costs and in less time.
Major benefits of the 3D CoSeedis™ Dose Response Assay include:
  • It integrates the response of 300 micro-tissues per applied dose and data point
  • It provides statistically relevant drug response differences very fast and very accurately
  • It’s ultra-sensitive and picks up minimal differences in the response rate of different compounds – ideal for optimization studies
  • It eliminates the need for expensive and time consuming xenograft experiments
Interested to learn more about the 3D CoSeedis™ Dose Response Assay or any of the other in chip-assay family members? I am looking forward to answering all your questions.

   Best regards

   Marco Leu, PhD
   Sales & Operation
   abc biopply ag

   Direct Email / Phone +41 (0)79 834 95 56

Back to overview


Contact us